$3.23
0.092.87%
At Close: -
$3.45
0.226.81%
After Hours: Jul 11, 8:10 AM EDT
15 minutes delayed
Comments
Loading...
Minerva Neurosciences
NERVNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Minerva Neurosciences (NASDAQ:NERV) Stock, Analyst Ratings, Price Targets, Forecasts
Minerva Neurosciences Inc has a consensus price target of $7 based on the ratings of 2 analysts. The high is $7 issued by HC Wainwright & Co. on May 2, 2024. The low is $7 issued by HC Wainwright & Co. on May 2, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 2, 2024, February 27, 2024, and August 2, 2023, respectively. With an average price target of $9.67 between HC Wainwright & Co., there's an implied 199.28% upside for Minerva Neurosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Minerva Neurosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | Buy Now | 116.72% | HC Wainwright & Co. | Douglas Tsao | $11 → $7 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | 240.56% | HC Wainwright & Co. | Douglas Tsao | → $11 | Reiterates | Neutral → Neutral | Get Alert |
| 08/02/2023 | Buy Now | 240.56% | HC Wainwright & Co. | Douglas Tsao | $8 → $11 | Maintains | Neutral | Get Alert |
| 05/16/2023 | Buy Now | 147.68% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | Neutral → Neutral | Get Alert |
| 05/02/2023 | Buy Now | 147.68% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | → Neutral | Get Alert |
| 03/09/2023 | Buy Now | 147.68% | HC Wainwright & Co. | Douglas Tsao | → $8 | Reiterates | → Neutral | Get Alert |
| 11/10/2022 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao | — | Downgrade | Buy → Neutral | Get Alert |
| 10/17/2022 | Buy Now | — | JMP Securities | Jason Butler | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 03/04/2022 | Buy Now | 54.8% | HC Wainwright & Co. | Douglas Tsao | $80 → $40 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Minerva Neurosciences (NERV) stock?
The latest price target for Minerva Neurosciences (NASDAQ:NERV) was reported by HC Wainwright & Co. on May 2, 2024. The analyst firm set a price target for $7.00 expecting NERV to rise to within 12 months (a possible 102.90% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Minerva Neurosciences (NERV)?
The latest analyst rating for Minerva Neurosciences (NASDAQ:NERV) was provided by HC Wainwright & Co., and Minerva Neurosciences maintained their neutral rating.
When was the last upgrade for Minerva Neurosciences (NERV)?
There is no last upgrade for Minerva Neurosciences
When was the last downgrade for Minerva Neurosciences (NERV)?
The last downgrade for Minerva Neurosciences Inc happened on November 10, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Minerva Neurosciences Inc.
When is the next analyst rating going to be posted or updated for Minerva Neurosciences (NERV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Minerva Neurosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Minerva Neurosciences was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
Is the Analyst Rating Minerva Neurosciences (NERV) correct?
While ratings are subjective and will change, the latest Minerva Neurosciences (NERV) rating was a maintained with a price target of $11.00 to $7.00. The current price Minerva Neurosciences (NERV) is trading at is $3.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.